Tango Therapeutics Information
Contact top employees from
Tango Therapeutics
Summary
Tango Therapeutics is a private company that has been in the industry for 8 years. The company currently specializes in the Biotechnology, Pharmaceuticals, Biotechnology areas. The position of the President & CEO is occupied by Barbara Weber. Its headquarters is located at Cambridge, Massachusetts, USA. The number of employees ranges from 25 to 100. The Tango Therapeutics annual revenue is estimated at < 1M. Total funding of the company - $165M. To connect with Tango Therapeutics employee register on SignalHire.
Industries
Biotechnology
Headquarters Location
Employees Size
100-200 employees
Specialties
cancer, pharmaceutical research, functional genomics, drug discovery, synthetic lethality
SIC Code
2834
DMA Code
Greater Boston
Founded
2017
Operating Status
Merger Pending
Competitors
Founded | Type | Employees | Revenue | Funding | |
|---|---|---|---|---|---|
| 1998 | Public Company | 1 - 25 | < 1M | $190M | |
| 2009 | Public Company | 1.0K - 5.0K | 45M | $634.9M | |
| 2010 | Privately Held | 25 - 100 | 7.1M | $158M | |
| 2018 | Privately Held | 25 - 100 | 2.5M | $113.8M | |
| 2016 | Privately Held | 25 - 100 | < 1M | $39M | |
| 2013 | Public Company | 1.0K - 5.0K | 106M | $1.5B | |
| 2010 | Privately Held | 25 - 100 | 1.3M | $81M | |
| 1993 | Public Company | 1.0K - 5.0K | 50.2M | $526.4M | |
| 2009 | Privately Held | 25 - 100 | 5.6M | $197.7M | |
| 2019 | Privately Held | 25 - 100 | 3M | $51M | |
| 2013 | Privately Held | 100 - 250 | 20M | $216.6M | |
| 2019 | Privately Held | 25 - 100 | 1.7M | $148M | |
| 2018 | Privately Held | 100-200 | - | $- | |
| 2020 | Privately Held | 200-500 | - | $- | |
| 2011 | - | 100-200 | - | $- | |
| 2012 | - | 100-200 | - | $- | |
| 2014 | - | 100-200 | - | $- | |
| 2021 | - | 100-200 | - | $- |
Employees Turnover 3 quarter 2025
Number of employees switched from or switched to
Total number all of employee turnover
Current employees switched from
Length of Employment
Employee tenure at Tango Therapeutics shows a diverse range of experience levels:
14% have been with the company for less than 1 year23% for 1–2 years17% for 3–4 years29% for 5–7 years11% for 8–10 years6% have over 11 years of service at Tango TherapeuticsEx-employees positions
In Company
In New Company
Contact top employees from
Tango Therapeutics
Gina Calvanese
Manager, Administration
Sandra Sutera
VP, Head of Program & Portfolio Management, Chief of Staff to the President of R&D
Andre Mignault
Director Clinical Translational Research
Heather DiBenedetto
Chief Development Operations Officer
Donna Fitzgerald
Associate Director, Clinical Scientist
Erica Arkin
Senior Recruiter
Madhavi Bandi
Principal Scientist
Adam Crystal
President, Research and Development
Gabriella Santone
Associate Biosample Manager
Salam Shaaban
Vice President, Biology
Tom Garafalo
Head of Facilities
Jen Morawiak
Director, Clinical Trials
Brian Haines
Vice President, Pharmacology
Hongming Li
Director, Process Chemistry, CMC
Scott Throner
Director, Medicinal Chemistry
Matthew Tonini
Senior Scientist II
Kasia Handing
Associate Director
Liliana Rao
Associate Director, Lab Operations
Charles Davis
Senior Vice President
Brian Doyon
Scientist II, Biochemistry
Simon Liang
Manager R&D Operations
Katelyn Powe
Associate Manager, Business Development & Legal Affairs
Alice Tsai
Executive Director, Head of DMPK and Preclinical Safety
Kerri Raso
Director, IRT Systems
Colin Liang
Senior Director, Head of Process Chemistry
Julie Fogarty
Senior Director, Corporate Counsel
Emily Linendoll
Associate Director, Communications
Tram Anh Tran
Senior Manager, Regulatory Operations
Joe Acosta
Associate Director, IT Infrastructure and Cloud Services
Jeff Pagliei
Vice President Information Technology
